PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT). (12th June 2019)

• Record Type: Journal Article
• Authors: Vassilakopoulos, T.P.; Papageorgiou, S.G.; Michail, M.; Angelopoulou, M.K.; Kourti, G.; Kalpadakis, C.; Kotsopoulou, M.; Leonidopoulou, T.; Konstantinidou, P.; Kotsianidis, I.; Boutsis, D.; Michali, E.; Sachanas, S.; Terpos, E.; Karianakis, G.; Poziopoulos, C.; Vadikolia, C.; Pigaditou, A.; Vrakidou, E.; Anargyrou, K.; Symeonidis, A.; Stefanoudaki, E.; Hadjiharissi, E.; Papaioannou, M.; Gainaru, G.; Tsirogianni, M.; Katodritou, E.; Karmiris, T.; Variami, E.; Pappa, V.; Dimopoulos, M.; Roussou, P.; Panayitidis, P.; Konstantopoulos, K.; Pangalis, G.A.;
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 266
• Page End: 267
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.76_2630
• Languages: English
• ISSNs: 0278-0232